-
Multiparametric MRI Differentiates Small Hepatocellular Carcinoma (<3 cm) from Benign Liver Lesions Associated with Budd-Chiari Syndrome
The “International Liver Disease – Hepatic Vascular Disease Column” is an academic column initiated by Dr. Xingshun Qi from the Department of Gastroenterology at General Hospital of Northern Theater Command, in collaboration with the editorial team of International Liver Disease. This column regularly collects and organizes research progress in the field of hepatic vascular diseases,…
-
High Frequency of Type 3 Dendritic Cells in CD1c+DCs on Day 28 Post-Allo-HSCT as a Potential Marker for Severe GVHD in Pediatric Patients
llogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) and Chimeric Antigen Receptor T-cell (CAR-T) therapy have become crucial in the treatment of leukemia. However, the effectiveness and safety of these treatments continue to be hot topics of research. Recent breakthrough studies have provided valuable insights, particularly in the treatment of children with relapsed/refractory B-cell acute lymphoblastic leukemia…
-
2024 CSCO Guidelines Conference | Prof. Yao Zhu: Combining the Latest Research to Guide Prostate Cancer Treatment Guidelines for Patient Protection
Prostate cancer is a malignant tumor occurring in the male reproductive system. Although the incidence in China is lower than in Western countries, it has rapidly increased in recent years, now ranking as the sixth most common male malignancy. With rapid advances in related research, updating prostate cancer treatment guidelines based on the latest evidence-based…
-
La Vente de Stéroïdes: Ce que vous devez savoir
La Vente de Stéroïdes: Ce que vous devez savoir La vente de stéroïdes est un sujet controversé et souvent mal compris. Les stéroïdes, également connus sous le nom de substances…
-
2024 South-North Forum | Prof. Xiaowei Qi: Advancements in Dual Target Neoadjuvant Therapy for HER2-Positive Breast Cancer
In the first-line treatment of advanced HER2-positive breast cancer, the combination of pyrotinib and trastuzumab has introduced a new therapeutic model. The complementary mechanisms of large and small molecules have achieved a median progression-free survival (mPFS) of 24.3 months, setting a new standard for first-line treatment of advanced HER2-positive breast cancer. This combination therapy is…
-
EBMT Roundtable Discussion | Professor Shaoyan Hu’s Team: Efficacy and Safety of Allo-HSCT and CAR-T Cell Therapy in Pediatric Leukemia Patients
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) and Chimeric Antigen Receptor T-cell (CAR-T) therapy have become crucial in the treatment of leukemia. However, the effectiveness and safety of these treatments continue to be hot topics of research. Recent breakthrough studies have provided valuable insights, particularly in the treatment of children with relapsed/refractory B-cell acute lymphoblastic leukemia…
-
Winstrol como tomar: Guía completa para aprovechar al máximo este esteroide
Winstrol como tomar: Guía completa para aprovechar al máximo este esteroide Si estás buscando información sobre cómo tomar Winstrol de manera efectiva, has llegado al lugar indicado. En esta guía,…
-
Utilisation de Trenbolone: Ce que vous devez savoir
Utilisation de Trenbolone: Ce que vous devez savoir L’utilisation de Trenbolone est une pratique courante parmi les culturistes et les athlètes à la recherche de gains musculaires significatifs. Cependant, il…
Connecting Medical Expertise through Media